This Issue
- China: Gaining Entry
- Spotlight
-
Pharmaceutical companies in a fierce race to bring their products to market have begun to regard economically burgeoning China as an R&D paradise.
- A World Away
- development
-
Finding solutions for the neglected tropical diseases that affect one billion people worldwide requires not only a commitment to conduct sorely needed research, but also a rethinking of drug development’s value proposition.
- Biotechs and the Public Market
- development
-
After a disastrous first half of 2008, the question becomes: Are IPOs still fueling the biotech industry?
- Outside Perspective
- management
-
As the biopharmaceutical industry undergoes massive, transformational change, many companies are looking outside the industry to fill leadership positions.
- Europe: The Hard Cell
- development
-
Stem cell research receives official funding from the European Parliament. But the opportunities this presents for EU researchers remain complex and controversial.
- Simulating Science
- management
-
Through clinical trial simulation, researchers can generate a fuller understanding of their drug and its potential effects, leading to better designed—and possibly less expensive—trials.
- The Meaning of Meta-Analyses
- commercialization
-
Meta-analyses can play a role in advancing scientific knowledge
for any given drug. But if poorly designed or hastily conducted, they can be damaging for an approved medicine.
MediaCast
- Harnessing Science
- Mediacast
-
Dr. Louis Renzetti, vice president and global head of RNA therapeutics at Roche, explains the enormous potential of RNAi technology in the development of new medicines.
Web Exclusives
- Evidence-Based Development and Smarter Sourcing
-
Jay Norman, president of Quintiles Consulting, discusses the changing landscape of drug development and suggests that better, evidence-based decisions, combined with smart sourcing strategies, will differentiate the future winners.
- An Unbalanced Burden
-
A Q&A with Dr. Kathleen Squires, director of the infectious disease department at Jefferson Medical College in Philadelphia, illuminates the gender differences in the diagnosis and treatment of HIV.
Columns
- Specialty Sales in the Global Marketplace
-
James Lennertz, head of global operations at Innovex, discusses the changing role of specialty sales reps.
- Safety through Standards
-
Paula Brown Stafford, executive vice president of global data management at Quintiles, discusses how universal data standards can help ensure better patient safety across all phases of clinical research.
Most Read
